d-alpha tocopherol has been researched along with fenofibrate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bhatia, G; Pandeti, S; Shukla, A; Sonkar, R; Tadigoppula, N | 1 |
| Bhatia, G; Dodda, RP; Palnati, GR; Sashidhara, KV; Sonkar, R | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bellamy, FD; Chaput, E; Edgar, AD; Maubrou-Sanchez, D | 1 |
| Badiou, S; Baillat, V; Cristol, JP; Dupuy, AM; Merle De Boever, C; Reynes, J | 1 |
| Ceska, R; Hilgertová, J; Kvasnicka, J; Skrha, J; Stulc, T; Weiserová, H | 1 |
| De Leeuw, I; Engelen, W; Manuel-y-Keenoy, B; Van Gaal, L; Vertommen, J | 1 |
| Antonini, R; Antonini, TM; Arca, M; Di Angelantonio, E; Diczfalusy, U; Iuliano, L; Micheletta, F; Montali, A; Natoli, S; Riggi, S | 1 |
| Chen, CH; Chen, ET; Ho, HO; Ke, WT; Sheu, MT; Wei, JD | 1 |
| Chen, YC; Ho, HO; Ke, WT; Lin, YM; Sheu, MT; Su, YD; Wu, JY | 1 |
| Coffin, J; Pelletier, AL; Rojas-Roldan, L | 1 |
| Bunjes, H; Roese, E | 1 |
| Atneriya, U; Kapoor, D; Maheshwari, R; Sainy, J | 1 |
2 review(s) available for d-alpha tocopherol and fenofibrate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Vision Loss in Older Adults.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antihypertensive Agents; Ascorbic Acid; Bevacizumab; Blindness; Cataract; Cataract Extraction; Diabetic Retinopathy; Fenofibrate; Glaucoma; Humans; Hypolipidemic Agents; Intravitreal Injections; Light Coagulation; Macular Degeneration; Mass Screening; Practice Guidelines as Topic; Ranibizumab; Vision Disorders; Vision, Low; Vitamin E; Vitamins | 2016 |
4 trial(s) available for d-alpha tocopherol and fenofibrate
| Article | Year |
|---|---|
Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults.
Topics: Adult; Anti-Retroviral Agents; Apolipoprotein A-I; Apolipoprotein C-III; Apolipoproteins B; Apolipoproteins C; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Copper; Female; Fenofibrate; HIV Infections; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Triglycerides; Vitamin E | 2004 |
Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes.
Topics: Acetylglucosaminidase; Adult; Aged; alpha-Tocopherol; Ascorbic Acid; Cholesterol; Czech Republic; Diabetes Mellitus, Type 2; Drug Administration Schedule; E-Selectin; Endothelium; Female; Fenofibrate; Fibrinolysis; Glutathione; Humans; Hyperlipidemias; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Plasminogen Activator Inhibitor 1; Simvastatin; Superoxide Dismutase; Time Factors; Triglycerides; Vascular Endothelial Growth Factor A; von Willebrand Factor | 2004 |
Effects of micronized fenofibrate and vitamin E on in vitro oxidation of lipoproteins in patients with type 1 diabetes mellitus.
Topics: Adult; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 1; Dosage Forms; Double-Blind Method; Female; Fenofibrate; Humans; Hypolipidemic Agents; Lipoproteins; Male; Patient Selection; Placebos; Vitamin E | 2005 |
Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
Topics: Adult; alpha-Tocopherol; Atorvastatin; Biomarkers; Drug Combinations; Female; Fenofibrate; Heptanoic Acids; Humans; Hydroxycholesterols; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Ketocholesterols; Lipids; Lipoproteins; Male; Middle Aged; Models, Biological; Oxidative Stress; Pyrroles | 2007 |
8 other study(ies) available for d-alpha tocopherol and fenofibrate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.
Topics: Animals; Antioxidants; Disease Models, Animal; Diterpenes; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Molecular Structure; Oxidation-Reduction; Rats; Rats, Inbred Strains | 2013 |
Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
Topics: Animals; Antioxidants; Chalcone; Disease Models, Animal; Drug Design; Hyperlipidemias; Hypolipidemic Agents; Indoles; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Molecular Structure; Polyethylene Glycols; Rats | 2014 |
Fenofibrate protects lipoproteins from lipid peroxidation: synergistic interaction with alpha-tocopherol.
Topics: Animals; Bezafibrate; Drug Synergism; Fenofibrate; Gemfibrozil; Hypolipidemic Agents; Lipid Peroxidation; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Rats; Rats, Sprague-Dawley; Vitamin E | 1999 |
Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.
Topics: Biological Availability; Drug Delivery Systems; Emulsifying Agents; Excipients; Fenofibrate; Hypolipidemic Agents; Polyethylene Glycols; Polysorbates; Propylene Glycol; Sodium Dodecyl Sulfate; Solubility; Triglycerides; Viscosity; Vitamin E | 2010 |
In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate.
Topics: Administration, Oral; Analysis of Variance; Area Under Curve; Biological Availability; Drug Carriers; Drug Delivery Systems; Emulsions; Fenofibrate; Humans; Nanoparticles; Particle Size; Polyethylene Glycols; Polysorbates; Solubility; Vitamin E | 2011 |
Drug release studies from lipid nanoparticles in physiological media by a new DSC method.
Topics: alpha-Tocopherol; Animals; Blood; Calorimetry, Differential Scanning; Crystallization; Drug Carriers; Drug Liberation; Emulsions; Fenofibrate; Lactones; Nanoparticles; Orlistat; Rapeseed Oil; Swine; Triglycerides; Ubiquinone | 2017 |
In vitro profiling of fenofibrate solid dispersion mediated tablet formulation to treat high blood cholesterol.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cholesterol; Fenofibrate; Polyethylene Glycols; Solubility; Tablets; Vitamin E; Water; X-Ray Diffraction | 2023 |